Generic Sweden (GENI) Q2 2025 earnings summary

Executive summary

• Revenue for Q2 2025 increased by 2.1% year-over-year to 44.3 MSEK, with EBIT up 33.6% to 9.0 MSEK and a strengthened EBIT margin of 20.3% (15.5%).

• Gross profit rose 11.9% to 19.4 MSEK, with gross margin improving to 43.8% (39.9%).

• SaaS services and new product launches, including RCS and DOCS, contributed to profitability and customer growth.

• Cash flow from operations was 10.8 MSEK, a significant improvement from -2.3 MSEK last year.

Financial highlights

• H1 2025 revenue grew 4.2% to 89.1 MSEK; gross profit up 15.5% to 39.2 MSEK; EBIT up 37.4% to 18.7 MSEK.

• EPS for Q2 was 0.58 SEK (0.44 SEK); H1 EPS was 1.21 SEK (0.89 SEK).

• Cash and cash equivalents at period end were 22.2 MSEK (13.3 MSEK).

• Solid equity ratio at 60.3% (54.8%).

• Dividend of 19.7 MSEK paid during the quarter.

Outlook and guidance

• Management targets higher revenue growth, supported by strong customer feedback and a robust product portfolio.

• Continued focus on SaaS and secure communication solutions expected to drive future growth.